 Biotin
"Biotin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.
| Descriptor ID |
D001710
|
| MeSH Number(s) |
D03.383.129.308.080 D08.211.096
|
| Concept/Terms |
Biotin- Biotin
- Vitamin H
- H, Vitamin
Biokur- Biokur
- Biocur Brand of Biotin
- Biotin Biocur Brand
Biotin Gelfert- Biotin Gelfert
- Gelfert, Biotin
- Ziethen Brand of Biotin
- Biotin Ziethen Brand
Biotin Hermes- Biotin Hermes
- Hermes, Biotin
- Hermes Brand of Biotin
- Biotin Hermes Brand
Biotin-ratiopharm- Biotin-ratiopharm
- Biotin ratiopharm
- Biotinratiopharm
- ratiopharm Brand of Biotin
- Biotin ratiopharm Brand
Rombellin- Rombellin
- Simons Brand of Biotin
- Biotin Simons Brand
Deacura- Deacura
- Dermapharm Brand of Biotin
- Biotin Dermapharm Brand
Gabunat- Gabunat
- Strathmann Brand of Biotin
- Biotin Strathmann Brand
Medebiotin- Medebiotin
- Medea Brand of Biotin Sodium Salt
medobiotin- medobiotin
- Medopharm Brand of Biotin
- Biotin Medopharm Brand
Biotine Roche- Biotine Roche
- Roche, Biotine
- Roche Brand of Biotin
- Biotin Roche Brand
|
Below are MeSH descriptors whose meaning is more general than "Biotin".
Below are MeSH descriptors whose meaning is more specific than "Biotin".
This graph shows the total number of publications written about "Biotin" by people in UAMS Profiles by year, and whether "Biotin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 1 | 2 | | 2019 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2012 | 1 | 0 | 1 | | 2011 | 4 | 0 | 4 | | 2010 | 3 | 0 | 3 | | 2008 | 2 | 0 | 2 | | 2007 | 0 | 2 | 2 | | 2006 | 1 | 2 | 3 | | 2005 | 2 | 0 | 2 | | 2004 | 2 | 0 | 2 | | 2002 | 0 | 1 | 1 | | 2001 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1996 | 0 | 2 | 2 | | 1995 | 0 | 1 | 1 | | 1993 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Biotin" by people in Profiles over the past ten years.
-
Marwaha D, Singh N, Gautam S, Rai N, Tiwari P, Bakshi AK, Kumar A, Agarwal N, Sharma M, Shukla RP, Mishra PR. Pemetrexed-loaded supramolecular acetal-functionalized pH-responsive nanocarriers selectively induce apoptosis through biotin receptors to enhance antitumor efficacy. Colloids Surf B Biointerfaces. 2025 Jan; 245:114247.
-
Mehanna LE, Osborne AR, Peterson CA, Berron BJ. Spontaneous Alignment of Myotubes Through Myogenic Progenitor Cell Migration. Tissue Eng Part A. 2024 Mar; 30(5-6):192-203.
-
Mock DM, Stowell SR, Franco RS, Kyosseva SV, Nalbant D, Schmidt RL, Cress GA, Strauss RG, Cancelas JA, von Goetz M, North AK, Widness JA. Antibodies against biotin-labeled red blood cells can shorten posttransfusion survival. Transfusion. 2022 04; 62(4):770-782.
-
Trambas CM, Liu KC, Luu H, Louey W, Lynch C, Yen T, Sikaris KA. Further assessment of the prevalence of biotin supplementation and its impact on risk. Clin Biochem. 2019 Mar; 65:64-65.
-
Obeidat M, McConnell KA, Li X, Bui B, Stathakis S, Papanikolaou N, Rasmussen K, Ha CS, Lee SE, Shim EY, Kirby N. DNA double-strand breaks as a method of radiation measurements for therapeutic beams. Med Phys. 2018 Jul; 45(7):3460-3465.
-
Mock DM. Biotin: From Nutrition to Therapeutics. J Nutr. 2017 08; 147(8):1487-1492.
-
Schmidt RL, Mock DM, Franco RS, Cohen RM, North AK, Cancelas JA, Geisen C, Strauss RG, Vlaar AP, Nalbant D, Widness JA. Antibodies to biotinylated red blood cells in adults and infants: improved detection, partial characterization, and dependence on red blood cell-biotin dose. Transfusion. 2017 06; 57(6):1488-1496.
-
Kuruvilla DJ, Widness JA, Nalbant D, Schmidt RL, Mock DM, An G, Veng-Pedersen P. Estimation of adult and neonatal RBC lifespans in anemic neonates using RBCs labeled at several discrete biotin densities. Pediatr Res. 2017 Jun; 81(6):905-910.
-
Peyro Saint Paul L, Debruyne D, Bernard D, Mock DM, Defer GL. Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis. Expert Opin Drug Metab Toxicol. 2016; 12(3):327-44.
-
Widness JA, Kuruvilla DJ, Mock DM, Matthews NI, Nalbant D, Cress GA, Schmidt RL, Strauss RG, Zimmerman MB, Veng-Pedersen P. Autologous Infant and Allogeneic Adult Red Cells Demonstrate Similar Concurrent Post-Transfusion Survival in Very Low Birth Weight Neonates. J Pediatr. 2015 Nov; 167(5):1001-6.
-
Sedel F, Bernard D, Mock DM, Tourbah A. Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis. Neuropharmacology. 2016 Nov; 110(Pt B):644-653.
-
Dakshinamurti K, Bagchi RA, Abrenica B, Czubryt MP. Microarray analysis of pancreatic gene expression during biotin repletion in biotin-deficient rats. Can J Physiol Pharmacol. 2015 Dec; 93(12):1103-10.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|